Welcome to YLOAN.COM
yloan.com » Marketing » Vision Shopsters: Diabetes Market Forecast To 2015
Marketing Advertising Branding Careers-Employment Change-Management Customer Service Entrepreneurialism Ethics Marketing-Direct Negotiation Outsourcing PR Presentation Resumes-Cover-Letters Sales Sales-Management Sales-Teleselling Sales-Training Strategic-Planning Team-Building Top7-or-Top10-Tips Workplace-Communication aarkstore corporate advantages development collection global purchasing rapidshare grinding wildfire shipping trading economy wholesale agency florida attorney strategy county consumer bills niche elliptical

Vision Shopsters: Diabetes Market Forecast To 2015

Gain instant access to the most up-to-date information on the diabetes market

. Scour in-depth profiles of brands and diabetes drug makers to target and seize market share, optimize return on investment, prove the value of your assets, and set proactive brand strategies.

In addition to market forecasts, you' ll find primary data from physicians worldwide as well as industry leaders in R&D and marketing. Their input provides knowledgeable, fresh insights on emerging treatments and unmet needs in the diabetes space.

Get accurate, honest market outlooks

Save money and valuable time with sales projections, patent information and clinical data - all in context, so you can compare brands, classes and companies.


Answer critical questions about your diabetes portfolio :

Are you entering the diabetes market - or expanding your current portfolio?

How does your developing drug compare to brands on the market? Does your drug stand a chance?

Are you working on another DPP-4 inhibitor or GLP-1 analog - and ignoring a market push toward novel therapies?

Have you been hit by the FDA' s cardiovascular guidelines? Are you adequately prepared for regulatory review?

Are you trying to out-license a diabetes product?

How will your early-stage diabetes compound fare in tomorrow' s market? Is there room for your drug, too?

Profiled Diabetes Portfolios

Amylin

Bristol-Myers Squibb

Boehringer Ingelheim

Eli Lilly

GlaxoSmithKline

Merck

Novo Nordisk

Roche

Sanofi-Aventis

Takeda

All Companies Included in Report

Alkermes, Amylin, AstraZeneca, Biocon, Biodel, Boehringer Ingelheim, Bristol-Myers Squibb, Eisai, Eli Lilly, Forest Labs, Generex, Genzyme, Gideon Richter, GlaxoSmithKline, Human Genome Sciences, Ipsen, MacroGenics, Mannkind, Merck, Novartis, Novo Nordisk, Osiris, Pfizer, Phenomix, Quark, Roche, Sanofi-Aventis, Takeda, Tolerx, Transition Therapeutics, Vivus

For more information on the report, kindly visit :

http://www.visionshopsters.com/product/3307/Diabetes-Market-Forecast-to-2015.html

or email us your query at : info@visionshopsters.com

----------------------------------------------

by: Vision Shopsters
Earn More Money after Pursuing the Share Market Intraday Tips Video Marketing Global Cancer Biomarkers Market (2010 - 2015) - Aarkstore Enterprise Facebook and Social Websites - Newest Marketing Opportunities 5 Wow Social Media Marketing Tips How Website Marketing Can Be Of Help Ecn Style Trading Vs Market Makers The importance of social media in your marketing campaigns Why PayBox Is A Scam 3 Crucial Affiliate Marketing Tips That Will Help You to Make Some Real Affiliate Sales 5 Tactics To Increase Your Affiliate Marketing Sales Fast And Simply. How To Make Money With Affiliate Marketing Discover Why Bookmarking Demon Is So Widely Used For Online Marketing
print
www.yloan.com guest:  register | login | search IP(216.73.216.111) California / Anaheim Processed in 0.017645 second(s), 7 queries , Gzip enabled , discuz 5.5 through PHP 8.3.9 , debug code: 56 , 2380, 66,
Vision Shopsters: Diabetes Market Forecast To 2015 Anaheim